McCombe William D.
Reporting owner on Forms 3, 4 and 5, CIK 1878824.
McCombe William D. reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-20.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| CTKB · Cytek Biosciences, Inc.CIK 1831915 | officer (Chief Financial Officer) | 1 | 2026-11-20 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | M exercised | +6,320 | 141,013 | Form 4 | |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | F withheld for tax | -2,127 | $5.92 | 138,886 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | M exercised | +13,051 | 151,937 | Form 4 | |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | F withheld for tax | -4,392 | $5.92 | 147,545 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | M exercised | +16,049 | 163,594 | Form 4 | |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | F withheld for tax | -5,401 | $5.92 | 158,193 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Restricted Stock Units, derivative | 2026-11-18 | M exercised | -6,320 | $0 | 37,929 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Restricted Stock Units, derivative | 2026-11-18 | M exercised | -13,051 | $0 | 121,811 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Restricted Stock Units, derivative | 2026-11-18 | M exercised | -16,049 | $0 | 213,993 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001878824-26-000005 | Cytek Biosciences, Inc. | 2026-11-20 |